Edition:
United Kingdom

People: Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

14.17USD
22 Jul 2019
Change (% chg)

-- (--)
Prev Close
$14.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
208,210
52-wk High
$16.38
52-wk Low
$2.62

Hemrajani, Rekha 

Ms. Rekha Hemrajani is Director of the company. Rekha Hemrajani, M.B.A. has more than 20 years of biopharmaceutical industry experience and has extensive expertise in all aspects of corporate and business development, financing, and strategic planning. Ms. Hemrajani serves as chief financial officer and chief operating officer of Arcus Biosciences, Inc. where she leads finance, investor relations, corporate communications, business and corporate development, strategic planning, and human resources. Previously, she was chief operating officer for FLX Bio, chief financial officer and senior vice president of business and financial operations at 3-V Biosciences, vice president, head of licensing and mergers and acquisitions at Onyx Pharmaceuticals, Inc., and vice president of business development at Exelixis, Inc. Ms. Hemrajani began her career in investment banking at Credit Suisse and Lehman Brothers. Ms. Hemrajani earned a B.S. in economics and computer science from the University of Michigan and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --